NewAmsterdam Pharma Company NV

NAMS · NASDAQ

$21.50+$1.03 (+5.03%)TodayMarket closed ·
Prev close $20.47

Who owns NAMS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 5.3% of NAMS’s shares.

  • Frazier Healthcare Partners0.9%
  • Glazer Capital, LLC0.7%
  • Alyeska Investment Group, L.P.0.6%
  • D. E. Shaw & Co., L.P.0.6%
  • Next 6 largest institutions2.5%
  • All other shareholders94.7%
Top institutional holders of NAMS
HolderShares% of shares
Frazier Healthcare Partners1.00M0.86%
Glazer Capital, LLC812.68K0.70%
Alyeska Investment Group, L.P.753.49K0.64%
D. E. Shaw & Co., L.P.706.84K0.60%
Millennium Management LLC679.39K0.58%
EcoR1 Capital, LLC587.62K0.50%
Goldman Sachs & Company, Inc.501.29K0.43%
MYDA Advisors LLC410.00K0.35%
Governors Lane LP350.00K0.30%
Radcliffe Capital Management, L.P.338.98K0.29%

Largest mutual fund holders

Top mutual fund holders of NAMS
HolderShares% of shares
First Trust Merger Arbitrage Fund123.74K0.11%
Saba Capital Income & Opportunities Fund19.12K0.02%
Fidelity NASDAQ Composite Index Fund8.91K0.01%
Morgan Creek - Exos Active SPAC Arbitrage ETF2.48K0.00%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $226.50K (1 trade) and sold $11.38M (9 trades) of NAMS on the open market.

Latest NAMS insider transactions
InsiderTypeSharesValue
Kastelein Johannes Jacob PieterOption exercise50.25K—
Kastelein Johannes Jacob PieterSale50.25K$1.26M
Kastelein Johannes Jacob PieterOption exercise50.25K—
Davidson Michael H.Buy10.00K$226.50K
Smither John WSale1.60K$40.51K
Gunning Robert WilliamAward14.00K—
Gunning Robert WilliamAward3.20K—
Kastelein Johannes Jacob PieterOption exercise125.00K—
Kastelein Johannes Jacob PieterSale125.00K$3.36M
Kastelein Johannes Jacob PieterOption exercise125.00K—

Short interest

Settled Sep 30, 2026

Shares short
19.05M
Days to cover
9.39
% of shares outstanding
16.29%
Average daily volume
2.03M
Change since last report
+21.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.